[ad_1]
12-Jul-2018-08: 08
A new blood test that evaluates four protein biomarkers significantly improves the detection of lung cancer risk, announced today. International Health Agency. Cancer Research (IARC).
This method helps to identify people who should have a CT scan, a radiological radiological examination commonly used for the diagnosis of this disease.
One of the leading researchers in the study. Mattias Johansson told Efe that "it is the first time that blood tests are used in a context of early detection of lung cancer in healthy people."
This new model takes into account the tobacco consumption and analyzes the blood levels of the CA125, Pro-SFTPB, CYFRA 21-1 and CEA proteins, some of which, like CYFRA 21-1, are already analyzed individually to diagnose other types of cancer, such as l & # 39; ovary.
The study analyzed the blood of lung cancer patients while they had not yet developed the disease.
This new system, according to Johansson, identifies 63% of future patients, among smokers and ex-smokers, while the percentage with current criteria for comprehensive follow-up is about 42%.
IARC Director Christopher Wild said in a statement that "avoiding smoking is the best way to reduce the risk of developing lung cancer in smokers and ex-smokers who are at high risk, early detection plays a key role in reducing this disease. "
Lung cancer accounts for 20% of all cancer deaths worldwide and the vast majority of 80-90% are caused by smoking, such as confirmed IARC, an entity of the World Health Organization (WHO).
Cancer
Lung cancer
Health
Tobacco
smoke
[ad_2]
Source link
